Financials
Financial year 2025
Gross margin
€ 169,791
▼ 19% vs 2024
Profit
Healthy€ 124,215
▼ 51% vs 2024
Debts
Low€ 40,997
▼ 11% vs 2024
Drs Pipeleers & Marichal from Roosdaal, company number BE0841472129, closed financial year 2025 with a result of € 124,215 after tax. For that financial year Drs Pipeleers & Marichal recorded a gross margin of € 169,791 and equity of € 2 million. Compared with financial year 2024, the result moved from € 254,562 to € 124,215. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 9, 2026.
What happened at Drs Pipeleers & Marichal?
What happened at Drs Pipeleers & Marichal in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 124,215 (▼ 51% vs 2024). filed late Source: NBB ↗
- New establishment in Roosdaal. KBO
- Start of the company according to the CBE. KBO
- Daniel Pipeleers became a director. NBB
- Miriam Marichal became a director. NBB
In short
From € 122,594 profit in 2022 to € 124,215 profit in 2025.
Paid € 276,232 in corporate taxes since 2022.
Best year ever: 2024, with € 254,562 profit.
Paid out € 36,000 in dividends to the owners in total.
A new publication or filing at Drs Pipeleers & Marichal? We notify you, reason included.
Follow Drs Pipeleers & MarichalNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Drs Pipeleers & Marichal are Daniel Pipeleers and Miriam Marichal. The same people are also behind OPUS, BETA - CELL and Center for Beta Cell Therapy in Diabetes.
Directors
According to the 2025 annual accounts
Daniel Pipeleers
Director
Also active at: OPUS, BETA - CELL, Center for Beta Cell Therapy in Diabetes
since 2011
Miriam Marichal
Director
since 2011
Establishments
Establishment units
Physical locations of this company
Benedenstraat 5
1761 Roosdaal
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0841.472.129
- VAT number
- BE 0841.472.129
- Registered office
- Benedenstraat 5, 1761 Roosdaal
- Names & denominations
- Drs Pipeleers & Marichal
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 December 2011
- Peppol
- Active · Active since 14 Nov 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige gespecialiseerde wetenschappelijke en technische activiteiten